{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:46:56Z","timestamp":1786654016495,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373786"],"award-info":[{"award-number":["82373786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574316"],"award-info":[{"award-number":["82574316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504666"],"award-info":[{"award-number":["82504666"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bcp.2026.118195","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:29:41Z","timestamp":1782516581000},"page":"118195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Microcolin A, a lipopeptide from marine cyanobacteria, suppresses the non-small cell lung carcinoma by regulating the C-terminal of Hsp90\u03b1 and ROS\/ERK signaling pathways"],"prefix":"10.1016","volume":"252","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8735-049X","authenticated-orcid":false,"given":"Zhanying","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodong","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghua","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haobing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2026.118195_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.bcp.2026.118195_b0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bcp.2026.118195_b0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41392-025-02243-6","article-title":"Advances in molecular pathology and therapy of non-small cell lung cancer","volume":"10","author":"Huang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2026.118195_b0020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/acs.orglett.8b04050","article-title":"Highly convergent total synthesis and assignment of absolute configuration of majusculamide D, a potent and selective cytotoxic metabolite from Moorea sp","volume":"21","author":"Caro-Diaz","year":"2019","journal-title":"Org. Lett."},{"issue":"6","key":"10.1016\/j.bcp.2026.118195_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/md23060243","article-title":"Marine natural products as anticancer agents 3.0","volume":"23","author":"Alves","year":"2025","journal-title":"Mar. Drugs"},{"issue":"9","key":"10.1016\/j.bcp.2026.118195_b0030","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1021\/acs.jnatprod.9b00549","article-title":"Cytotoxic microcolin lipopeptides from the marine cyanobacterium moorea producens","volume":"82","author":"Yu","year":"2019","journal-title":"J. Nat. Prod."},{"issue":"10","key":"10.1016\/j.bcp.2026.118195_b0035","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41589-022-01061-z","article-title":"Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides","volume":"18","author":"Li","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118195_b0040","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41392-023-01667-2","article-title":"Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPalpha\/beta","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2026.118195_b0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/15384047.2020.1736482","article-title":"Heat shock proteins as biomarkers of lung cancer","volume":"21","author":"Mittal","year":"2020","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2026.118195_b0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cell.2012.06.047","article-title":"Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition","volume":"150","author":"Taipale","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118195_b0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/128_2012_356","article-title":"Hsp90: structure and function","volume":"328","author":"Jackson","year":"2013","journal-title":"Top. Curr. Chem."},{"issue":"20","key":"10.1016\/j.bcp.2026.118195_b0060","article-title":"Icaritin represses autophagy to promote colorectal cancer cell apoptosis and sensitized low-temperature photothermal therapy via targeting HSP90-TXNDC9 interactions","volume":"12","author":"He","year":"2025","journal-title":"Adv. Sci. (Weinh)."},{"issue":"8","key":"10.1016\/j.bcp.2026.118195_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17081341","article-title":"Targeting HSP90 with ganetespib to induce CDK1 degradation and promote cell death in hepatoblastoma","volume":"17","author":"Jung","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.bcp.2026.118195_b0070","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41580-023-00640-9","article-title":"Structural and functional complexity of HSP90 in cellular homeostasis and disease","volume":"24","author":"Chiosis","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118195_b0075","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1038\/s41598-021-83533-1","article-title":"Environmental stressors, complex interactions and marine benthic communities' responses","volume":"11","author":"Carrier-Belleau","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2026.118195_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/md22050191","article-title":"Novel bioactive natural products from marine-derived penicillium fungi: a review (2021-2023)","volume":"22","author":"Lv","year":"2024","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bcp.2026.118195_b0085","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","article-title":"Drug affinity responsive target stability (DARTS) for small-molecule target identification","volume":"1263","author":"Pai","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"6141","key":"10.1016\/j.bcp.2026.118195_b0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118195_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156321","article-title":"Ganoderic acid T, a novel activator of pyruvate carboxylase, exhibits potent anti-liver cancer activity","volume":"170","author":"Lei","year":"2025","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.bcp.2026.118195_b0100","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bbamcr.2011.10.008","article-title":"Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers","volume":"1823","author":"Jhaveri","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.bcp.2026.118195_b0105","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.118195_b0110","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bmc.2010.10.029","article-title":"A systematic protocol for the characterization of Hsp90 modulators","volume":"19","author":"Matts","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2026.118195_b0115","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1074\/jbc.M512406200","article-title":"Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90: evidence that coumarin antibiotics disrupt Hsp90 dimerization","volume":"281","author":"Allan","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118195_b0120","article-title":"Targeting HSP90 inhibits proliferation and induces apoptosis through AKT1\/ERK pathway in lung cancer","volume":"12","author":"Niu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118195_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112540","article-title":"Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells","volume":"203","author":"Wu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2026.118195_b0130","first-page":"1287","article-title":"The HSP90 inhibitor onalespib potentiates 177Lu\u2011DOTATATE therapy in neuroendocrine tumor cells","volume":"55","author":"Lundsten","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bcp.2026.118195_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114864","article-title":"Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K\/AKT\/mTOR and MAPK signaling pathways","volume":"195","author":"Yu","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118195_b0140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41420-024-02251-5","article-title":"TFAP2A drives non-small cell lung cancer (NSCLC) progression and resistance to targeted therapy by facilitating the ESR2-mediated MAPK pathway","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.bcp.2026.118195_b0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13062-024-00512-y","article-title":"ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathway","volume":"19","author":"Zhai","year":"2024","journal-title":"Biol. Direct"},{"issue":"1","key":"10.1016\/j.bcp.2026.118195_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/biom15010103","article-title":"Anti-inflammatory and anti-migratory effects of morin on non-small-cell lung cancer metastasis via inhibition of NLRP3\/MAPK signaling pathway","volume":"15","author":"Arjsri","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2026.118195_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1548810","article-title":"Rapamycin combined with osimertinib alleviated non-small cell lung cancer by regulating the PARP, Akt\/mTOR, and MAPK\/ERK signaling pathways","volume":"12","author":"Ma","year":"2025","journal-title":"Front. Mol. Biosci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118195_b0160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41419-020-2317-3","article-title":"Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS\/MAPK signaling pathway in vitro and in vivo","volume":"11","author":"Fan","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bcp.2026.118195_b0165","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70501","article-title":"Cinobufagin enhances the sensitivity of cisplatin-resistant lung cancer cells to chemotherapy by inhibiting the PI3K\/AKT and MAPK\/ERK pathways","volume":"29","author":"Zhang","year":"2025","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118195_b0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40659-021-00330-w","article-title":"Lotus leaf flavonoids induce apoptosis of human lung cancer A549 cells through the ROS\/p38 MAPK pathway","volume":"54","author":"Jia","year":"2021","journal-title":"Biol. Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.118195_b0175","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2024.13330","article-title":"Exploring the therapeutic potential of rabdoternin E in lung cancer treatment: targeting the ROS\/p38 MAPK\/JNK signaling pathway","volume":"30","author":"Jin","year":"2024","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2026.118195_b0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/2278-330X.187563","article-title":"Lung cancer in India: current status and promising strategies","volume":"5","author":"Parikh","year":"2016","journal-title":"South Asian J Cancer."},{"issue":"9","key":"10.1016\/j.bcp.2026.118195_b0185","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2174\/156652412803306657","article-title":"Inhibiting HSP90 to treat cancer: a strategy in evolution","volume":"12","author":"Whitesell","year":"2012","journal-title":"Curr. Mol. Med."},{"issue":"8","key":"10.1016\/j.bcp.2026.118195_b0190","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1039\/C4CC07284G","article-title":"N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes","volume":"51","author":"Wang","year":"2015","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.bcp.2026.118195_b0195","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1471-2407-11-468","article-title":"Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells","volume":"11","author":"Eskew","year":"2011","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.118195_b0200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41419-025-08330-4","article-title":"Small-molecule inhibitor of C\u2011terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells","volume":"17","author":"David","year":"2025","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118195_b0205","doi-asserted-by":"crossref","DOI":"10.3892\/or.2025.9018","article-title":"C\u2011terminal HSP90 inhibitor NCT\u201158 impairs the cancer stem\u2011like phenotype and enhances chemotherapy efficacy in TNBC","volume":"55","author":"Jung","year":"2026","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.bcp.2026.118195_b0210","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.7150\/ijbs.79965","article-title":"YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR\/MAPK pathway and abrogating autophagy in non-small cell lung cancer","volume":"19","author":"Ning","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118195_b0215","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7150\/ijbs.85443","article-title":"Promotion of ROS-mediated apoptosis, G2\/M arrest, and autophagy by naringenin in non-small cell lung cancer","volume":"20","author":"Chang","year":"2024","journal-title":"Int. J. Biol. Sci."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:13:34Z","timestamp":1786652014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226005344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S0006295226005344"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118195","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microcolin A, a lipopeptide from marine cyanobacteria, suppresses the non-small cell lung carcinoma by regulating the C-terminal of Hsp90\u03b1 and ROS\/ERK signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118195"}}